Adaptilens A-IOL
Cataract Surgery / Presbyopia
Pre-clinicalActive
Key Facts
About Adaptilens
Adaptilens is pioneering a biomimetic approach to intraocular lenses (IOLs) for cataract surgery, seeking to address the significant limitations of current monofocal and premium IOLs. The company's lead product, the Adaptilens A-IOL, is designed to physically change shape in response to the eye's natural focusing mechanism, aiming to provide a full range of high-quality vision without common side effects like halos and glare. With a $17.5M Series A financing round announced, the company is advancing its technology through preclinical development. Its leadership combines clinical, scientific, and commercial expertise from the ophthalmology and medical device sectors.
View full company profile